[PDF][PDF] The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients
JR Dijkstra, GH De Bock, MJE Mourits - International Journal of …, 2005 - academia.edu
To the Editor: With much interest we read the article by Tjalma et al.(1), in which they
evaluated the cost-effectiveness of routine follow-up in patients with endometrial cancer …
evaluated the cost-effectiveness of routine follow-up in patients with endometrial cancer …
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations
…, J Oosting, JA De Hullu, M JE Mourits… - Journal of the National …, 2021 - repub.eur.nl
BACKGROUND: Endometrial cancer (EC) risk in BReast CAncer gene 1/2 (BRCA1/2)
mutation carriers is uncertain; therefore, we assessed this in a large Dutch nationwide cohort …
mutation carriers is uncertain; therefore, we assessed this in a large Dutch nationwide cohort …